| Source: |
| Type: |
| Adenosine triphosphate (ATP) is the source of energy for use and storage at the cellular level. Cellular ATP levels are critical for cell survival, and several reports have shown that reductions in cellular ATP levels can lead to apoptosis and other types of cell death in cancer cells, depending on the level of depletion. Adenosine triphosphate (ATP) is one of the main biochemical components of the tumor microenvironment (TME), where it can promote tumor progression or tumor suppression depending on its concentration and on the specific ecto-nucleotidases and receptors expressed by immune and cancer cells. Cancer cells, unlike normal cells, derive as much as 60% of their ATP from glycolysis via the “Warburg effect”, and the remaining 40% is derived from mitochondrial oxidative phosphorylation. |
| 6815- | EMD, | NMR-based Metabolomic Techniques Identify the Toxicity of Emodin in HepG2 Cells |
| - | in-vitro, | Liver, | HepG2 |
| 1322- | EMD, | The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers |
| - | Review, | Var, | NA |
| 5495- | EP, | Irreversible electroporation in focal therapy for prostate cancer: current status and future directions |
| - | Review, | Pca, | NA |
| 4251- | FA, | Antidepressant-Like Effect of Ferulic Acid via Promotion of Energy Metabolism Activity |
| - | in-vivo, | AD, | NA |
| 6981- | Form, | Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
| 6971- | Form, | In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa |
| - | vitro+vivo, | Cerv, | HeLa |
| 5205- | Gallo, | Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells |
| - | in-vitro, | Endo, | ISH |
| 935- | Gallo, | Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 7195- | GBE, | Mitochondrial effects of Ginkgo biloba extract |
| - | Review, | AD, | NA |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
| - | in-vitro, | Cerv, | NA |
| 7321- | Gos, | The potential roles of gossypol as anticancer agent: advances and future directions |
| - | Review, | Var, | NA |
| 7310- | Gos, | Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells |
| - | in-vitro, | AML, | NA |
| 7335- | Gra, | Effect of Annona muricata (Soursop) on Patients with Cancer: A Systematic Review |
| - | Review, | Var, | NA |
| 845- | Gra, | A Review on Annona muricata and Its Anticancer Activity |
| - | Review, | Var, | NA |
| - | in-vitro, | SCC, | SCC25 |
| 836- | Gra, | Graviola: A Novel Promising Natural-Derived Drug That Inhibits Tumorigenicity and Metastasis of Pancreatic Cancer Cells In Vitro and In Vivo Through Altering Cell Metabolism |
| - | vitro+vivo, | PC, | NA |
| 1232- | Gra, | Graviola: A Systematic Review on Its Anticancer Properties |
| - | Review, | Var, | NA |
| 7482- | H2, | Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application |
| - | Review, | Var, | NA | - | Review, | IBD, | NA | - | Review, | Stroke, | NA | - | Review, | Sepsis, | NA | - | Review, | AD, | NA |
| 7483- | H2, | Cisplatin, | Molecular hydrogen attenuates cisplatin-induced nephrotoxicity by modulating β-hydroxybutyrate metabolism |
| - | in-vivo, | Nor, | HK-2 |
| 3767- | H2, | The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges |
| - | Review, | AD, | NA |
| 2512- | H2, | Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch |
| - | in-vivo, | Asthma, | NA |
| 7503- | H2S, | Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells |
| - | Review, | Var, | NA |
| 2879- | HNK, | Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function |
| - | in-vitro, | Lung, | H226 | - | in-vivo, | NA, | NA |
| 2887- | HNK, | Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming |
| - | in-vitro, | AD, | BV2 |
| 960- | HNK, | Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth |
| - | vitro+vivo, | BC, | MCF7 | - | vitro+vivo, | BC, | MDA-MB-231 |
| 886- | HPT, | Impact of hyper- and hypothermia on cellular and whole-body physiology |
| - | Analysis, | Var, | NA |
| 7775- | IBC, | Isobavachalcone Induces Multiple Cell Death in Human Triple-Negative Breast Cancer MDA-MB-231 Cells |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 7636- | Ins, | Myo-Inositol: Pharmacokinetics, Biological Functions, and Therapeutic Potential in Liver Protection: Insights from Preclinical Models |
| - | Review, | Nor, | NA |
| 7744- | ISL, | Isoliquiritigenin suppresses fatty acid synthesis and cancer cell migration in anaplastic thyroid carcinoma through AMPK/SREBF1 pathway |
| - | vitro+vivo, | Thyroid, | NA |
| 7755- | ISL, | Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 7758- | ISL, | Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications |
| - | Review, | Ovarian, | NA |
| 7816- | ISQ, | Isoquercitrin Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Gastric Cancer Cells |
| - | in-vitro, | GC, | AGS | - | in-vitro, | GC, | HGC27 |
| 7983- | itraC, | Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells |
| - | in-vitro, | Nor, | HUVECs |
| 8028- | IVM, | Ivermectin as an Alternative Anticancer Agent: A Review of Its Chemical Properties and Therapeutic Potential |
| - | Review, | Var, | NA |
| 8027- | IVM, | Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin |
| - | Review, | Var, | NA |
| 8022- | IVM, | Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage |
| - | vitro+vivo, | RCC, | NA |
| 8047- | IVM, | The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug |
| - | Review, | Var, | NA |
| 8040- | IVM, | Ivermectin, a potential anticancer drug derived from an antiparasitic drug |
| - | Review, | Var, | NA |
| 1070- | IVM, | Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation |
| - | vitro+vivo, | GBM, | NA |
| 7910- | IVT, | Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | H1975 |
| 8089- | KAE, | Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1 |
| - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Melanoma, | B16-F10 |
| 8092- | KAE, | Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells |
| - | in-vitro, | Colon, | HCT116 | - | in-vitro, | Colon, | DLD1 |
| 8067- | KAE, | Cisplatin, | Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin |
| - | in-vitro, | HNSCC, | NA |
| 8162- | LapC, | Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2 |
| - | in-vitro, | Melanoma, | MEL526 | - | in-vitro, | Melanoma, | MEL697 | - | in-vitro, | Melanoma, | MEL103 |
| 8178- | Las, | Lasiokaurin suppresses breast cancer growth by blocking autophagic flux and regulating cellular energy homeostasis |
| - | in-vitro, | BC, | NA |
| 8237- | LCA, | Role of Licochalcone A in Potential Pharmacological Therapy: A Review |
| - | Review, | Var, | NA |
| 8235- | LCA, | Anticancer effects of licochalcones: A review of the mechanisms |
| - | Review, | Var, | NA |
| 8213- | LCA, | Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | H322 |
| 8332- | LIN, | Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | NA, | NIH-3T3 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | HEK293 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:21 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid